Who Owns MEDS?
— Institutional Ownership & 13F Holdings
$0.00
+0.00 (+0.00%)
Market Cap
—
Shares Outstanding
—
Institutional Holders
9
Total Inst. Value
$443K
% of Float Held
—
QoQ Holder Change
—
Institutional data as of Q1 2024
Top 10 Institutional Holders(Q1 2024)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $342K | 33,382 |
| 2 | BlackRock Inc. | $84K | 8,220 |
| 3 | Tower Research Capital LLC (TRC) | $10K | 1,019 |
| 4 | Blue Trust, Inc. | $4K | 357 |
| 5 | UBS Group AG | $3K | 246 |
| 6 | VANGUARD GROUP INC | $148 | 14,548 |
| 7 | WELLS FARGO & COMPANY/MN | $82 | 8 |
| 8 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | $0 | 0 |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $0 | 10,198 |
Famous Fund Managers
Frequently Asked Questions
How many institutional investors hold MEDS?
As of Q1 2024, 9 institutional investors report holding MEDS (null) in their 13F filings.
Which hedge fund owns the most MEDS?
The largest institutional holder of MEDS is RENAISSANCE TECHNOLOGIES LLC with $342K in shares.
Are institutions buying or selling MEDS?
This quarter, 9 institutions opened new positions in MEDS and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.